MedCity News

Survey: Employers Expect Healthcare Costs to Increase by 9% in 2026, Driven by GLP-1s and Cancer Care

Side Effects Make Viking’s Oral Obesity Drug a Tough Pill for Investors to Swallow

Viking Therapeutics’ obesity pill met weight reduction goals of its Phase 2 test, but gastrointestinal side effects led to high discontinuation rates. Even so, analysts see potential for a lower dose of the Viking drug as a maintenance therapy.

By Frank Vinluan

MedCity Influencers, Opinion

Artificial Intelligence hologram robot and futuristic UI panel.

Bridging the Gap: AI Agents Address Healthcare’s Supply and Demand Challenges

By unlocking the benefits of AI in healthcare, the industry can stabilize the unbalanced supply and demand caused by limited resources and aging global populations.

By Trent Norris

MedCity Influencers

How Improved Interoperability Drives Greater Health Equity

Interoperability offers the potential to improve the quality of care by providing more comprehensive, accurate health information to doctors and other providers, to patients and their caregivers, as well as to healthcare payers, and others with a valid need.

By Steven Lane

Latest Video

Latest News

Events

To Be or Not to Be: Addressing the Challenge of AI-Generated Hallucinations in Healthcare

As healthcare organizations experiment with AI, they're learning more about the technology as they generate evidence that these tools improve efficiency and reduce costs.

By Stephanie Baum

Hospitals, Health Tech Providers,

A senior woman sits at the table and measures blood pressure at her home.

University Hospitals Taps HealthSnap to Close Gaps in Hypertension Care

University Hospitals is rolling out a remote patient monitoring program for hypertensive patients using HealthSnap’s platform. The Cleveland-based health system expects to enroll up to 5,000 patients by mid-2026, with plans to expand the program to other chronic conditions in the future.

By Katie Adams

Policy, MedCity Influencers

It Is Time For The Life Sciences Industry To Rethink Its Relationship with HIPAA

As manufacturers play an active role in the patients’ healthcare journey, the boundaries between manufacturers and healthcare providers/payers are becoming increasingly blurry.

By Nirmal Vemanna

The Human Algorithm: What AI Can’t Replace in Pharma Engagement

At a time when AI is reshaping pharma, Reverba Global CEO Cheryl Lubbert explained in an interview why empathy, context, and ethics still require a human touch.

By Stephanie Baum

Consumer / Employer

Report: Small Businesses Work to Balance Rising Costs and Health Coverage

Small businesses are struggling with rising costs and tariffs, but many are still looking to maintain or increase health coverage, according to a recent report from Chase.

By Marissa Plescia

Hospitals, Payers, Consumer / Employer, Providers

Closeup of many neon colored price stickers

Same Surgery, $220K Apart: Why Providers & Employers Need to Rethink Value Amid Price Disparities

A new Trilliant Health report reveals vast price variation for identical healthcare services, even for procedures delivered at the exact same facility. Allison Oakes, Trilliant’s chief research officer, urged providers to prove they are delivering true value for the cost and pressed employers to leverage their purchasing power to demand higher-value care.

By Katie Adams

BioPharma, Pharma

FDA Approval Expands Novo Nordisk’s Wegovy to the Fatty Liver Disease MASH

Novo Nordisk’s GLP-1 drug Wegovy expanded its label to include the metabolic disorder known as MASH. Analysts say there’s room for many MASH drugs with the treatment landscape expected to shape up to include combinations of therapies bringing different approaches to this fatty liver disease.

By Frank Vinluan

MedCity Influencers

For Rehab Providers, Outcomes Are the Strategy Not Just the Scorecard

Outcomes are no longer a nice-to-have or a post-hoc justification for care provided. They are a central currency of care in a system that’s shifting faster than ever toward accountability.

By Susan Lofton

MedCity Influencers

How Employers Can Build an Effective GLP-1 Strategy

Here are five guidelines to help employers balance health outcomes and financial responsibility to ensure that GLP-1 coverage is effective, affordable, and aligned with improved health and workforce well-being for employees and their families.

By Robert Andrews

Health Services

If You Value MedCity News, Take Our Audience Survey

Our readers play a vital role in our success. Take part in our Reader Survey and help us continue to grow!

By Stephanie Baum

Hospitals Providers,

One very large ceramic piggy bank on tall pile of US paper currency looking down on 6 much small piggy banks

Hospital Margins Grow, Yet Bad Debt & Expenses Continue to Climb

Hospital margins improved in June as revenue gains outpaced patient volume — but Kaufman Hall’s latest data shows that financial gaps between high- and low-performing organizations persist, with increasing expenses and bad debt threatening long-term stability.

By Katie Adams

Health Tech

GLP-1s Come With High Price Tags and Major Side Effects. Could Microdosing Be the Answer?

Noom recently launched a microdosing program for GLP-1s. However, some are concerned about the use of compounded GLP-1s in this program, as they are not FDA-approved.

By Marissa Plescia

BioPharma, Startups

In Tough Climate for Raising Money, VC Firm Hatteras Secures $200M for Two New Funds

Even with venture capital fundraising slowing down, Hatteras Venture Partners was able to close two new funds for investments in seed- and early-stage companies. We also have a recap of recent financings in the biotech sector.

By Frank Vinluan

MedCity Influencers

Telehealth Safe Harbor Is A Win-Win For Workers And Employers

Health plan sponsors have more flexibility and opportunities than before to improve healthcare access and steer their workforce toward high-quality, high-value care.

By Ami Parekh